Ellen Rosenberg - Net Worth and Insider Trading
Ellen Rosenberg Net Worth
The estimated net worth of Ellen Rosenberg is at least $4 Million dollars as of 2024-04-25. Ellen Rosenberg is the Chief Legal Officer of Amicus Therapeutics Inc and owns about 382,654 shares of Amicus Therapeutics Inc (FOLD) stock worth over $4 Million. Details can be seen in Ellen Rosenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ellen Rosenberg has not made any transactions after 2024-02-07 and currently still holds the listed stock(s).
Transaction Summary of Ellen Rosenberg
Ellen Rosenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ellen Rosenberg owns 1 companies in total, including Amicus Therapeutics Inc () .
Click here to see the complete history of Ellen Rosenberg’s form 4 insider trades.
Insider Ownership Summary of Ellen Rosenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Amicus Therapeutics Inc | 2024-02-07 | General Counsel & Corp. Secy |
Ellen Rosenberg Latest Holdings Summary
Ellen Rosenberg currently owns a total of 1 stock. Ellen Rosenberg owns 382,654 shares of Amicus Therapeutics Inc (FOLD) as of February 7, 2024, with a value of $4 Million.
Latest Holdings of Ellen Rosenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2024-02-07 | 382,654 | 10.54 | 4,033,173 |
Holding Weightings of Ellen Rosenberg
Ellen Rosenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Ellen Rosenberg has made a total of 10 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 30,000 shares on February 7, 2024, which brought Ellen Rosenberg around $390,000.
Insider Trading History of Ellen Rosenberg
- 1
Ellen Rosenberg Trading Performance
GuruFocus tracks the stock performance after each of Ellen Rosenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ellen Rosenberg is -12.45%. GuruFocus also compares Ellen Rosenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ellen Rosenberg within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ellen Rosenberg's insider trading performs compared to the benchmark.
Performance of Ellen Rosenberg
Average Return
8.95%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.55 | -12.45 | -24.77 | 8.95 | 46.41 | 13.52 |
| Relative Return to S&P 500(%) | -25.44 | -16 | -28.89 | -6.91 | 32.42 | 4.16 |
Ellen Rosenberg Ownership Network
Ownership Network List of Ellen Rosenberg
Ownership Network Relation of Ellen Rosenberg
Ellen Rosenberg Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Ellen Rosenberg is the General Counsel & Corp. Secy of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Ellen Rosenberg made 4 insider transaction in Amicus Therapeutics Inc () with a net sale of 126,839. Other recent insider transactions involving Amicus Therapeutics Inc () include a net sale of 645,546 shares made by John F Crowley , a net sale of 258,416 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc () in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.
Amicus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Ellen Rosenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Ellen Rosenberg. You might contact Ellen Rosenberg via mailing address: C/o Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury Nj 08560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
